The full agenda for this year’s STAT Summit is now live, bringing together executives, policymakers, scientists, and investors to reflect on the year and take a closer look at the state of health and medicine today — and what it may signal for the industry in 2027 and beyond.
From the breakthroughs changing what’s possible in medicine — like our sit-down with Paola Arlotta, the researcher growing brain tissue in a dish — to a look at policy decisions affecting the industry with Rep. Jake Auchincloss, to big questions around AI, drug pricing, psychedelics, drug development, and more — the agenda offers a wide-ranging look at the biggest questions facing leaders across health and medicine in 2026.